GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 215 filers reported holding GENOMIC HEALTH INC in Q2 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,624,000 | +262.4% | 38,687 | +210.8% | 0.05% | +283.3% |
Q2 2019 | $724,000 | -70.9% | 12,449 | -64.9% | 0.01% | -66.7% |
Q1 2019 | $2,487,000 | +64.3% | 35,510 | +51.1% | 0.04% | +50.0% |
Q4 2018 | $1,514,000 | +518.0% | 23,507 | +574.5% | 0.02% | +700.0% |
Q3 2018 | $245,000 | – | 3,485 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |